Interventions to support adherence to oral anticancer therapies: research challenges, lessons learned, and strategies to overcome them from Australia and Switzerland

Carole Bandiera, Xiomara Skrabal Ross, Evelina Cardoso, Dorothea Wagner, Chantal Csajka, Ian Olver, Pandora Patterson, Vijayaprakash Suppiah, Kate M. Gunn, Marie Schneider

Research output: Contribution to journalComment/debatepeer-review

1 Citation (Scopus)


Not monitoring adherence to oral anticancer therapies (OAT) can lead to poor clinical outcomes, including premature death as reported by Foulon et al. (Acta Clin Belg 66(2):85–96, 2011) and Greer et al. (Oncologist 21(3):354–76, 2016). Barriers to the implementation of supportive cancer care interventions in medication adherence occur with multiple hospital sites, cancer diagnoses, and numerous healthcare professionals. This commentary describes challenges and strategies from two OAT adherence trials in Australia and Switzerland to assist researchers in the design and implementation of future interprofessional trials.

Original languageEnglish
Pages (from-to)3655-3659
Number of pages5
JournalSupportive Care in Cancer
Issue number5
Publication statusPublished or Issued - May 2022
Externally publishedYes


  • Clinical trials
  • Implementation science
  • Medication adherence
  • Neoplasms
  • Oral anticancer therapies, Antineoplastic agents
  • Patient selection

ASJC Scopus subject areas

  • Oncology

Cite this